Rule-based computerized point of care decision support systems (SIgMA)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2012 - 2012
Project Lead
Dr. Tony Raj, Dr. Kedar Radhakrishna, Dr. Abijeet V Waghmare, Dr. Ryan Fernandez
Authors
Dr. Tony Raj, Dr. Kedar Radhakrishna, Dr. Abijeet V Waghmare, Dr. Ryan Fernandez
Project Status
completed
Project Type
St. John's Research Society